nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxyurea—hematologic cancer—muscle cancer	0.454	0.54	CtDrD
Hydroxyurea—head and neck cancer—muscle cancer	0.387	0.46	CtDrD
Hydroxyurea—RRM1—larynx—muscle cancer	0.00869	0.295	CbGeAlD
Hydroxyurea—RRM2—Vinorelbine—Vincristine—muscle cancer	0.0025	1	CbGdCrCtD
Hydroxyurea—RRM2—embryo—muscle cancer	0.00231	0.0784	CbGeAlD
Hydroxyurea—RRM2—renal system—muscle cancer	0.00175	0.0594	CbGeAlD
Hydroxyurea—RRM1—smooth muscle tissue—muscle cancer	0.00151	0.0512	CbGeAlD
Hydroxyurea—RRM1—renal system—muscle cancer	0.00145	0.0493	CbGeAlD
Hydroxyurea—RRM2—tendon—muscle cancer	0.00137	0.0463	CbGeAlD
Hydroxyurea—RRM2—bone marrow—muscle cancer	0.00132	0.0449	CbGeAlD
Hydroxyurea—RRM1—cardiac atrium—muscle cancer	0.0013	0.0442	CbGeAlD
Hydroxyurea—RRM2—vagina—muscle cancer	0.00127	0.043	CbGeAlD
Hydroxyurea—RRM2—head—muscle cancer	0.00117	0.0397	CbGeAlD
Hydroxyurea—RRM1—tendon—muscle cancer	0.00113	0.0385	CbGeAlD
Hydroxyurea—RRM2—testis—muscle cancer	0.00113	0.0384	CbGeAlD
Hydroxyurea—RRM1—bone marrow—muscle cancer	0.0011	0.0373	CbGeAlD
Hydroxyurea—RRM1—vagina—muscle cancer	0.00105	0.0357	CbGeAlD
Hydroxyurea—RRM1—head—muscle cancer	0.000973	0.033	CbGeAlD
Hydroxyurea—RRM1—testis—muscle cancer	0.00094	0.0319	CbGeAlD
Hydroxyurea—Mucosal inflammation—Etoposide—muscle cancer	0.000711	0.00574	CcSEcCtD
Hydroxyurea—Hepatotoxicity—Dactinomycin—muscle cancer	0.000704	0.00568	CcSEcCtD
Hydroxyurea—Skin necrosis—Methotrexate—muscle cancer	0.000675	0.00545	CcSEcCtD
Hydroxyurea—Febrile neutropenia—Etoposide—muscle cancer	0.000654	0.00528	CcSEcCtD
Hydroxyurea—Skin necrosis—Doxorubicin—muscle cancer	0.000584	0.00472	CcSEcCtD
Hydroxyurea—Ulcer—Dactinomycin—muscle cancer	0.000575	0.00464	CcSEcCtD
Hydroxyurea—Pulmonary fibrosis—Methotrexate—muscle cancer	0.000536	0.00433	CcSEcCtD
Hydroxyurea—Hyperuricaemia—Vincristine—muscle cancer	0.000524	0.00423	CcSEcCtD
Hydroxyurea—Hepatotoxicity—Etoposide—muscle cancer	0.00051	0.00411	CcSEcCtD
Hydroxyurea—Lung infiltration—Methotrexate—muscle cancer	0.000503	0.00406	CcSEcCtD
Hydroxyurea—Blood uric acid increased—Vincristine—muscle cancer	0.000495	0.00399	CcSEcCtD
Hydroxyurea—Hepatic failure—Dactinomycin—muscle cancer	0.000439	0.00355	CcSEcCtD
Hydroxyurea—Myelosuppression—Doxorubicin—muscle cancer	0.000435	0.00351	CcSEcCtD
Hydroxyurea—CYP2D6—renal system—muscle cancer	0.000432	0.0147	CbGeAlD
Hydroxyurea—RRM1—E2F transcription factor network—TFE3—muscle cancer	0.000429	0.181	CbGpPWpGaD
Hydroxyurea—Mucosal inflammation—Methotrexate—muscle cancer	0.000426	0.00344	CcSEcCtD
Hydroxyurea—Hyperuricaemia—Etoposide—muscle cancer	0.000424	0.00342	CcSEcCtD
Hydroxyurea—Ulcer—Etoposide—muscle cancer	0.000416	0.00336	CcSEcCtD
Hydroxyurea—Blood uric acid increased—Etoposide—muscle cancer	0.000401	0.00323	CcSEcCtD
Hydroxyurea—Skin hyperpigmentation—Methotrexate—muscle cancer	0.000396	0.0032	CcSEcCtD
Hydroxyurea—Hepatic failure—Vincristine—muscle cancer	0.000392	0.00317	CcSEcCtD
Hydroxyurea—Febrile neutropenia—Methotrexate—muscle cancer	0.000392	0.00316	CcSEcCtD
Hydroxyurea—Eruption—Methotrexate—muscle cancer	0.000383	0.00309	CcSEcCtD
Hydroxyurea—Skin exfoliation—Etoposide—muscle cancer	0.000376	0.00303	CcSEcCtD
Hydroxyurea—Mucosal inflammation—Doxorubicin—muscle cancer	0.000369	0.00298	CcSEcCtD
Hydroxyurea—Rash maculo-papular—Etoposide—muscle cancer	0.000358	0.00289	CcSEcCtD
Hydroxyurea—RRM2—E2F transcription factor network—TFE3—muscle cancer	0.000354	0.149	CbGpPWpGaD
Hydroxyurea—Bone marrow depression—Methotrexate—muscle cancer	0.000349	0.00282	CcSEcCtD
Hydroxyurea—Skin hyperpigmentation—Doxorubicin—muscle cancer	0.000343	0.00277	CcSEcCtD
Hydroxyurea—Febrile neutropenia—Doxorubicin—muscle cancer	0.000339	0.00274	CcSEcCtD
Hydroxyurea—Eruption—Doxorubicin—muscle cancer	0.000332	0.00268	CcSEcCtD
Hydroxyurea—Pancytopenia—Dactinomycin—muscle cancer	0.000324	0.00261	CcSEcCtD
Hydroxyurea—Hypomagnesaemia—Doxorubicin—muscle cancer	0.000321	0.00259	CcSEcCtD
Hydroxyurea—Neutropenia—Dactinomycin—muscle cancer	0.000319	0.00257	CcSEcCtD
Hydroxyurea—Hepatotoxicity—Methotrexate—muscle cancer	0.000305	0.00246	CcSEcCtD
Hydroxyurea—Skin ulcer—Methotrexate—muscle cancer	0.000303	0.00244	CcSEcCtD
Hydroxyurea—Bone marrow depression—Doxorubicin—muscle cancer	0.000302	0.00244	CcSEcCtD
Hydroxyurea—Stomatitis—Dactinomycin—muscle cancer	0.000296	0.00239	CcSEcCtD
Hydroxyurea—RRM1—E2F transcription factor network—TP73—muscle cancer	0.00029	0.122	CbGpPWpGaD
Hydroxyurea—Pancytopenia—Vincristine—muscle cancer	0.000289	0.00234	CcSEcCtD
Hydroxyurea—CYP2D6—head—muscle cancer	0.000289	0.0098	CbGeAlD
Hydroxyurea—Dysuria—Vincristine—muscle cancer	0.000285	0.0023	CcSEcCtD
Hydroxyurea—Neutropenia—Vincristine—muscle cancer	0.000285	0.0023	CcSEcCtD
Hydroxyurea—Blister—Doxorubicin—muscle cancer	0.000283	0.00229	CcSEcCtD
Hydroxyurea—CYP2D6—testis—muscle cancer	0.000279	0.00947	CbGeAlD
Hydroxyurea—Neuropathy peripheral—Vincristine—muscle cancer	0.000266	0.00215	CcSEcCtD
Hydroxyurea—Stomatitis—Vincristine—muscle cancer	0.000265	0.00214	CcSEcCtD
Hydroxyurea—Skin ulcer—Doxorubicin—muscle cancer	0.000262	0.00212	CcSEcCtD
Hydroxyurea—Hyperuricaemia—Methotrexate—muscle cancer	0.000254	0.00205	CcSEcCtD
Hydroxyurea—Hepatic enzyme increased—Methotrexate—muscle cancer	0.000249	0.00201	CcSEcCtD
Hydroxyurea—Ulcer—Methotrexate—muscle cancer	0.000249	0.00201	CcSEcCtD
Hydroxyurea—Chills—Dactinomycin—muscle cancer	0.000245	0.00198	CcSEcCtD
Hydroxyurea—Hallucination—Vincristine—muscle cancer	0.000243	0.00196	CcSEcCtD
Hydroxyurea—Alopecia—Dactinomycin—muscle cancer	0.000241	0.00195	CcSEcCtD
Hydroxyurea—Blood uric acid increased—Methotrexate—muscle cancer	0.00024	0.00194	CcSEcCtD
Hydroxyurea—RRM2—E2F transcription factor network—TP73—muscle cancer	0.000239	0.101	CbGpPWpGaD
Hydroxyurea—Erythema—Dactinomycin—muscle cancer	0.000238	0.00192	CcSEcCtD
Hydroxyurea—Pancytopenia—Etoposide—muscle cancer	0.000234	0.00189	CcSEcCtD
Hydroxyurea—Amenorrhoea—Doxorubicin—muscle cancer	0.000232	0.00188	CcSEcCtD
Hydroxyurea—Neutropenia—Etoposide—muscle cancer	0.000231	0.00186	CcSEcCtD
Hydroxyurea—Skin exfoliation—Methotrexate—muscle cancer	0.000225	0.00182	CcSEcCtD
Hydroxyurea—Angiopathy—Vincristine—muscle cancer	0.000221	0.00179	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Dactinomycin—muscle cancer	0.000221	0.00178	CcSEcCtD
Hydroxyurea—Infestation—Etoposide—muscle cancer	0.00022	0.00178	CcSEcCtD
Hydroxyurea—Infestation NOS—Etoposide—muscle cancer	0.00022	0.00178	CcSEcCtD
Hydroxyurea—Hyperuricaemia—Doxorubicin—muscle cancer	0.00022	0.00178	CcSEcCtD
Hydroxyurea—Anaemia—Dactinomycin—muscle cancer	0.00022	0.00177	CcSEcCtD
Hydroxyurea—Ulcer—Doxorubicin—muscle cancer	0.000216	0.00174	CcSEcCtD
Hydroxyurea—Neuropathy peripheral—Etoposide—muscle cancer	0.000216	0.00174	CcSEcCtD
Hydroxyurea—Alopecia—Vincristine—muscle cancer	0.000216	0.00174	CcSEcCtD
Hydroxyurea—Stomatitis—Etoposide—muscle cancer	0.000215	0.00173	CcSEcCtD
Hydroxyurea—Creatinine increased—Doxorubicin—muscle cancer	0.000214	0.00173	CcSEcCtD
Hydroxyurea—Malaise—Dactinomycin—muscle cancer	0.000214	0.00173	CcSEcCtD
Hydroxyurea—Neoplasm—Methotrexate—muscle cancer	0.000213	0.00172	CcSEcCtD
Hydroxyurea—Leukopenia—Dactinomycin—muscle cancer	0.000213	0.00172	CcSEcCtD
Hydroxyurea—Pulmonary oedema—Methotrexate—muscle cancer	0.00021	0.00169	CcSEcCtD
Hydroxyurea—Hepatobiliary disease—Etoposide—muscle cancer	0.000208	0.00168	CcSEcCtD
Hydroxyurea—Blood uric acid increased—Doxorubicin—muscle cancer	0.000208	0.00168	CcSEcCtD
Hydroxyurea—Discomfort—Dactinomycin—muscle cancer	0.0002	0.00161	CcSEcCtD
Hydroxyurea—Anaemia—Vincristine—muscle cancer	0.000196	0.00158	CcSEcCtD
Hydroxyurea—Skin exfoliation—Doxorubicin—muscle cancer	0.000195	0.00157	CcSEcCtD
Hydroxyurea—Oedema—Dactinomycin—muscle cancer	0.000194	0.00157	CcSEcCtD
Hydroxyurea—Infection—Dactinomycin—muscle cancer	0.000193	0.00156	CcSEcCtD
Hydroxyurea—Blood urea increased—Doxorubicin—muscle cancer	0.000193	0.00156	CcSEcCtD
Hydroxyurea—Hepatic failure—Methotrexate—muscle cancer	0.00019	0.00154	CcSEcCtD
Hydroxyurea—Leukopenia—Vincristine—muscle cancer	0.00019	0.00153	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Dactinomycin—muscle cancer	0.00019	0.00153	CcSEcCtD
Hydroxyurea—Rash maculo-papular—Doxorubicin—muscle cancer	0.000185	0.0015	CcSEcCtD
Hydroxyurea—Renal failure acute—Methotrexate—muscle cancer	0.000185	0.0015	CcSEcCtD
Hydroxyurea—Anorexia—Dactinomycin—muscle cancer	0.000185	0.00149	CcSEcCtD
Hydroxyurea—Neoplasm—Doxorubicin—muscle cancer	0.000185	0.00149	CcSEcCtD
Hydroxyurea—Convulsion—Vincristine—muscle cancer	0.000184	0.00149	CcSEcCtD
Hydroxyurea—Pulmonary oedema—Doxorubicin—muscle cancer	0.000182	0.00147	CcSEcCtD
Hydroxyurea—Angiopathy—Etoposide—muscle cancer	0.000179	0.00145	CcSEcCtD
Hydroxyurea—Chills—Etoposide—muscle cancer	0.000177	0.00143	CcSEcCtD
Hydroxyurea—Alopecia—Etoposide—muscle cancer	0.000175	0.00141	CcSEcCtD
Hydroxyurea—Oedema—Vincristine—muscle cancer	0.000173	0.0014	CcSEcCtD
Hydroxyurea—Infection—Vincristine—muscle cancer	0.000172	0.00139	CcSEcCtD
Hydroxyurea—Nervous system disorder—Vincristine—muscle cancer	0.00017	0.00137	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Vincristine—muscle cancer	0.00017	0.00137	CcSEcCtD
Hydroxyurea—Decreased appetite—Dactinomycin—muscle cancer	0.000169	0.00136	CcSEcCtD
Hydroxyurea—Fatigue—Dactinomycin—muscle cancer	0.000167	0.00135	CcSEcCtD
Hydroxyurea—Pain—Dactinomycin—muscle cancer	0.000166	0.00134	CcSEcCtD
Hydroxyurea—Anorexia—Vincristine—muscle cancer	0.000165	0.00133	CcSEcCtD
Hydroxyurea—Hepatic failure—Doxorubicin—muscle cancer	0.000165	0.00133	CcSEcCtD
Hydroxyurea—Renal failure acute—Doxorubicin—muscle cancer	0.00016	0.0013	CcSEcCtD
Hydroxyurea—Feeling abnormal—Dactinomycin—muscle cancer	0.00016	0.00129	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Etoposide—muscle cancer	0.00016	0.00129	CcSEcCtD
Hydroxyurea—Anaemia—Etoposide—muscle cancer	0.000159	0.00128	CcSEcCtD
Hydroxyurea—Malaise—Etoposide—muscle cancer	0.000155	0.00125	CcSEcCtD
Hydroxyurea—Dermatitis bullous—Doxorubicin—muscle cancer	0.000155	0.00125	CcSEcCtD
Hydroxyurea—Breast disorder—Methotrexate—muscle cancer	0.000155	0.00125	CcSEcCtD
Hydroxyurea—Leukopenia—Etoposide—muscle cancer	0.000154	0.00124	CcSEcCtD
Hydroxyurea—Body temperature increased—Dactinomycin—muscle cancer	0.000153	0.00124	CcSEcCtD
Hydroxyurea—Decreased appetite—Vincristine—muscle cancer	0.000151	0.00122	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Vincristine—muscle cancer	0.00015	0.00121	CcSEcCtD
Hydroxyurea—Fatigue—Vincristine—muscle cancer	0.000149	0.00121	CcSEcCtD
Hydroxyurea—Convulsion—Etoposide—muscle cancer	0.000149	0.0012	CcSEcCtD
Hydroxyurea—Pain—Vincristine—muscle cancer	0.000148	0.0012	CcSEcCtD
Hydroxyurea—Constipation—Vincristine—muscle cancer	0.000148	0.0012	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.000145	0.00117	CcSEcCtD
Hydroxyurea—Pancreatitis—Methotrexate—muscle cancer	0.000145	0.00117	CcSEcCtD
Hydroxyurea—Discomfort—Etoposide—muscle cancer	0.000145	0.00117	CcSEcCtD
Hydroxyurea—Face oedema—Doxorubicin—muscle cancer	0.000143	0.00115	CcSEcCtD
Hydroxyurea—Hypersensitivity—Dactinomycin—muscle cancer	0.000143	0.00115	CcSEcCtD
Hydroxyurea—Pancytopenia—Methotrexate—muscle cancer	0.00014	0.00113	CcSEcCtD
Hydroxyurea—Infection—Etoposide—muscle cancer	0.000139	0.00113	CcSEcCtD
Hydroxyurea—Asthenia—Dactinomycin—muscle cancer	0.000139	0.00112	CcSEcCtD
Hydroxyurea—Blood creatinine increased—Doxorubicin—muscle cancer	0.000139	0.00112	CcSEcCtD
Hydroxyurea—Dysuria—Methotrexate—muscle cancer	0.000138	0.00112	CcSEcCtD
Hydroxyurea—Neutropenia—Methotrexate—muscle cancer	0.000138	0.00112	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Etoposide—muscle cancer	0.000137	0.00111	CcSEcCtD
Hydroxyurea—Body temperature increased—Vincristine—muscle cancer	0.000137	0.00111	CcSEcCtD
Hydroxyurea—Skin disorder—Etoposide—muscle cancer	0.000136	0.0011	CcSEcCtD
Hydroxyurea—Breast disorder—Doxorubicin—muscle cancer	0.000134	0.00108	CcSEcCtD
Hydroxyurea—Anorexia—Etoposide—muscle cancer	0.000134	0.00108	CcSEcCtD
Hydroxyurea—Diarrhoea—Dactinomycin—muscle cancer	0.000133	0.00107	CcSEcCtD
Hydroxyurea—Infestation—Methotrexate—muscle cancer	0.000132	0.00106	CcSEcCtD
Hydroxyurea—Infestation NOS—Methotrexate—muscle cancer	0.000132	0.00106	CcSEcCtD
Hydroxyurea—Drowsiness—Methotrexate—muscle cancer	0.000132	0.00106	CcSEcCtD
Hydroxyurea—Stomatitis—Methotrexate—muscle cancer	0.000129	0.00104	CcSEcCtD
Hydroxyurea—Hypersensitivity—Vincristine—muscle cancer	0.000128	0.00103	CcSEcCtD
Hydroxyurea—Pancreatitis—Doxorubicin—muscle cancer	0.000126	0.00101	CcSEcCtD
Hydroxyurea—Dyspnoea—Etoposide—muscle cancer	0.000125	0.00101	CcSEcCtD
Hydroxyurea—Somnolence—Etoposide—muscle cancer	0.000125	0.00101	CcSEcCtD
Hydroxyurea—Hepatobiliary disease—Methotrexate—muscle cancer	0.000125	0.00101	CcSEcCtD
Hydroxyurea—Asthenia—Vincristine—muscle cancer	0.000124	0.001	CcSEcCtD
Hydroxyurea—Vomiting—Dactinomycin—muscle cancer	0.000123	0.000996	CcSEcCtD
Hydroxyurea—Rash—Dactinomycin—muscle cancer	0.000122	0.000987	CcSEcCtD
Hydroxyurea—Decreased appetite—Etoposide—muscle cancer	0.000122	0.000985	CcSEcCtD
Hydroxyurea—Pancytopenia—Doxorubicin—muscle cancer	0.000122	0.000982	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Etoposide—muscle cancer	0.000121	0.000978	CcSEcCtD
Hydroxyurea—Fatigue—Etoposide—muscle cancer	0.000121	0.000977	CcSEcCtD
Hydroxyurea—Pain—Etoposide—muscle cancer	0.00012	0.000969	CcSEcCtD
Hydroxyurea—Constipation—Etoposide—muscle cancer	0.00012	0.000969	CcSEcCtD
Hydroxyurea—Dysuria—Doxorubicin—muscle cancer	0.00012	0.000967	CcSEcCtD
Hydroxyurea—Neutropenia—Doxorubicin—muscle cancer	0.00012	0.000967	CcSEcCtD
Hydroxyurea—Haemoglobin—Methotrexate—muscle cancer	0.000119	0.00096	CcSEcCtD
Hydroxyurea—Diarrhoea—Vincristine—muscle cancer	0.000119	0.000957	CcSEcCtD
Hydroxyurea—Haemorrhage—Methotrexate—muscle cancer	0.000118	0.000955	CcSEcCtD
Hydroxyurea—Weight increased—Doxorubicin—muscle cancer	0.000117	0.000941	CcSEcCtD
Hydroxyurea—Feeling abnormal—Etoposide—muscle cancer	0.000116	0.000934	CcSEcCtD
Hydroxyurea—Nausea—Dactinomycin—muscle cancer	0.000115	0.00093	CcSEcCtD
Hydroxyurea—Dizziness—Vincristine—muscle cancer	0.000115	0.000925	CcSEcCtD
Hydroxyurea—Infestation NOS—Doxorubicin—muscle cancer	0.000114	0.000922	CcSEcCtD
Hydroxyurea—Infestation—Doxorubicin—muscle cancer	0.000114	0.000922	CcSEcCtD
Hydroxyurea—Drowsiness—Doxorubicin—muscle cancer	0.000114	0.000922	CcSEcCtD
Hydroxyurea—Neuropathy peripheral—Doxorubicin—muscle cancer	0.000112	0.000903	CcSEcCtD
Hydroxyurea—Stomatitis—Doxorubicin—muscle cancer	0.000111	0.000898	CcSEcCtD
Hydroxyurea—Body temperature increased—Etoposide—muscle cancer	0.000111	0.000896	CcSEcCtD
Hydroxyurea—Vomiting—Vincristine—muscle cancer	0.00011	0.000889	CcSEcCtD
Hydroxyurea—Rash—Vincristine—muscle cancer	0.000109	0.000882	CcSEcCtD
Hydroxyurea—Dermatitis—Vincristine—muscle cancer	0.000109	0.000881	CcSEcCtD
Hydroxyurea—Headache—Vincristine—muscle cancer	0.000109	0.000876	CcSEcCtD
Hydroxyurea—Hepatobiliary disease—Doxorubicin—muscle cancer	0.000108	0.000872	CcSEcCtD
Hydroxyurea—Angiopathy—Methotrexate—muscle cancer	0.000107	0.000867	CcSEcCtD
Hydroxyurea—Chills—Methotrexate—muscle cancer	0.000106	0.000857	CcSEcCtD
Hydroxyurea—Alopecia—Methotrexate—muscle cancer	0.000105	0.000844	CcSEcCtD
Hydroxyurea—Hypersensitivity—Etoposide—muscle cancer	0.000103	0.000835	CcSEcCtD
Hydroxyurea—Erythema—Methotrexate—muscle cancer	0.000103	0.000832	CcSEcCtD
Hydroxyurea—Haemoglobin—Doxorubicin—muscle cancer	0.000103	0.000832	CcSEcCtD
Hydroxyurea—Nausea—Vincristine—muscle cancer	0.000103	0.000831	CcSEcCtD
Hydroxyurea—Haemorrhage—Doxorubicin—muscle cancer	0.000102	0.000827	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—WT1—muscle cancer	0.000102	0.0429	CbGpPWpGaD
Hydroxyurea—Asthenia—Etoposide—muscle cancer	0.000101	0.000813	CcSEcCtD
Hydroxyurea—Diarrhoea—Etoposide—muscle cancer	9.61e-05	0.000775	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Methotrexate—muscle cancer	9.56e-05	0.000772	CcSEcCtD
Hydroxyurea—Anaemia—Methotrexate—muscle cancer	9.52e-05	0.000769	CcSEcCtD
Hydroxyurea—Angiopathy—Doxorubicin—muscle cancer	9.3e-05	0.000751	CcSEcCtD
Hydroxyurea—Malaise—Methotrexate—muscle cancer	9.29e-05	0.00075	CcSEcCtD
Hydroxyurea—Dizziness—Etoposide—muscle cancer	9.28e-05	0.000749	CcSEcCtD
Hydroxyurea—Leukopenia—Methotrexate—muscle cancer	9.22e-05	0.000745	CcSEcCtD
Hydroxyurea—Chills—Doxorubicin—muscle cancer	9.2e-05	0.000742	CcSEcCtD
Hydroxyurea—Alopecia—Doxorubicin—muscle cancer	9.06e-05	0.000731	CcSEcCtD
Hydroxyurea—Convulsion—Methotrexate—muscle cancer	8.93e-05	0.000721	CcSEcCtD
Hydroxyurea—Vomiting—Etoposide—muscle cancer	8.93e-05	0.000721	CcSEcCtD
Hydroxyurea—Erythema—Doxorubicin—muscle cancer	8.92e-05	0.00072	CcSEcCtD
Hydroxyurea—Rash—Etoposide—muscle cancer	8.85e-05	0.000715	CcSEcCtD
Hydroxyurea—Dermatitis—Etoposide—muscle cancer	8.84e-05	0.000714	CcSEcCtD
Hydroxyurea—Headache—Etoposide—muscle cancer	8.79e-05	0.00071	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	8.71e-05	0.000703	CcSEcCtD
Hydroxyurea—Discomfort—Methotrexate—muscle cancer	8.67e-05	0.0007	CcSEcCtD
Hydroxyurea—Infection—Methotrexate—muscle cancer	8.35e-05	0.000674	CcSEcCtD
Hydroxyurea—Nausea—Etoposide—muscle cancer	8.34e-05	0.000673	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Doxorubicin—muscle cancer	8.28e-05	0.000668	CcSEcCtD
Hydroxyurea—Nervous system disorder—Methotrexate—muscle cancer	8.25e-05	0.000666	CcSEcCtD
Hydroxyurea—Anaemia—Doxorubicin—muscle cancer	8.25e-05	0.000666	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Methotrexate—muscle cancer	8.23e-05	0.000665	CcSEcCtD
Hydroxyurea—Skin disorder—Methotrexate—muscle cancer	8.17e-05	0.000659	CcSEcCtD
Hydroxyurea—Malaise—Doxorubicin—muscle cancer	8.05e-05	0.000649	CcSEcCtD
Hydroxyurea—Anorexia—Methotrexate—muscle cancer	8.02e-05	0.000647	CcSEcCtD
Hydroxyurea—Leukopenia—Doxorubicin—muscle cancer	7.99e-05	0.000645	CcSEcCtD
Hydroxyurea—Convulsion—Doxorubicin—muscle cancer	7.73e-05	0.000624	CcSEcCtD
Hydroxyurea—RRM1—Fluoropyrimidine Activity—TP53—muscle cancer	7.71e-05	0.0325	CbGpPWpGaD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	7.54e-05	0.000609	CcSEcCtD
Hydroxyurea—Discomfort—Doxorubicin—muscle cancer	7.5e-05	0.000606	CcSEcCtD
Hydroxyurea—Dyspnoea—Methotrexate—muscle cancer	7.5e-05	0.000605	CcSEcCtD
Hydroxyurea—Somnolence—Methotrexate—muscle cancer	7.48e-05	0.000603	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—BUB1B—muscle cancer	7.44e-05	0.0314	CbGpPWpGaD
Hydroxyurea—Dyspepsia—Methotrexate—muscle cancer	7.4e-05	0.000598	CcSEcCtD
Hydroxyurea—RRM1—E2F transcription factor network—CDKN2A—muscle cancer	7.34e-05	0.0309	CbGpPWpGaD
Hydroxyurea—Decreased appetite—Methotrexate—muscle cancer	7.31e-05	0.00059	CcSEcCtD
Hydroxyurea—Oedema—Doxorubicin—muscle cancer	7.28e-05	0.000588	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Methotrexate—muscle cancer	7.26e-05	0.000586	CcSEcCtD
Hydroxyurea—Fatigue—Methotrexate—muscle cancer	7.25e-05	0.000585	CcSEcCtD
Hydroxyurea—Infection—Doxorubicin—muscle cancer	7.23e-05	0.000584	CcSEcCtD
Hydroxyurea—Pain—Methotrexate—muscle cancer	7.19e-05	0.00058	CcSEcCtD
Hydroxyurea—Nervous system disorder—Doxorubicin—muscle cancer	7.14e-05	0.000576	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Doxorubicin—muscle cancer	7.13e-05	0.000576	CcSEcCtD
Hydroxyurea—Skin disorder—Doxorubicin—muscle cancer	7.07e-05	0.000571	CcSEcCtD
Hydroxyurea—Anorexia—Doxorubicin—muscle cancer	6.94e-05	0.00056	CcSEcCtD
Hydroxyurea—Feeling abnormal—Methotrexate—muscle cancer	6.93e-05	0.000559	CcSEcCtD
Hydroxyurea—Body temperature increased—Methotrexate—muscle cancer	6.65e-05	0.000537	CcSEcCtD
Hydroxyurea—Dyspnoea—Doxorubicin—muscle cancer	6.49e-05	0.000524	CcSEcCtD
Hydroxyurea—Somnolence—Doxorubicin—muscle cancer	6.47e-05	0.000523	CcSEcCtD
Hydroxyurea—Dyspepsia—Doxorubicin—muscle cancer	6.41e-05	0.000517	CcSEcCtD
Hydroxyurea—RRM2—Fluoropyrimidine Activity—TP53—muscle cancer	6.35e-05	0.0268	CbGpPWpGaD
Hydroxyurea—Decreased appetite—Doxorubicin—muscle cancer	6.33e-05	0.000511	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Doxorubicin—muscle cancer	6.29e-05	0.000507	CcSEcCtD
Hydroxyurea—Fatigue—Doxorubicin—muscle cancer	6.28e-05	0.000507	CcSEcCtD
Hydroxyurea—Constipation—Doxorubicin—muscle cancer	6.23e-05	0.000503	CcSEcCtD
Hydroxyurea—Pain—Doxorubicin—muscle cancer	6.23e-05	0.000503	CcSEcCtD
Hydroxyurea—Hypersensitivity—Methotrexate—muscle cancer	6.2e-05	0.0005	CcSEcCtD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—MDM2—muscle cancer	6.19e-05	0.0261	CbGpPWpGaD
Hydroxyurea—RRM2—E2F transcription factor network—CDKN2A—muscle cancer	6.05e-05	0.0255	CbGpPWpGaD
Hydroxyurea—Asthenia—Methotrexate—muscle cancer	6.03e-05	0.000487	CcSEcCtD
Hydroxyurea—Feeling abnormal—Doxorubicin—muscle cancer	6e-05	0.000484	CcSEcCtD
Hydroxyurea—Body temperature increased—Doxorubicin—muscle cancer	5.76e-05	0.000465	CcSEcCtD
Hydroxyurea—Diarrhoea—Methotrexate—muscle cancer	5.75e-05	0.000464	CcSEcCtD
Hydroxyurea—Dizziness—Methotrexate—muscle cancer	5.56e-05	0.000449	CcSEcCtD
Hydroxyurea—Hypersensitivity—Doxorubicin—muscle cancer	5.36e-05	0.000433	CcSEcCtD
Hydroxyurea—Vomiting—Methotrexate—muscle cancer	5.35e-05	0.000432	CcSEcCtD
Hydroxyurea—Rash—Methotrexate—muscle cancer	5.3e-05	0.000428	CcSEcCtD
Hydroxyurea—Dermatitis—Methotrexate—muscle cancer	5.3e-05	0.000428	CcSEcCtD
Hydroxyurea—Headache—Methotrexate—muscle cancer	5.27e-05	0.000425	CcSEcCtD
Hydroxyurea—Asthenia—Doxorubicin—muscle cancer	5.22e-05	0.000422	CcSEcCtD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—MDM2—muscle cancer	5.1e-05	0.0215	CbGpPWpGaD
Hydroxyurea—Nausea—Methotrexate—muscle cancer	4.99e-05	0.000403	CcSEcCtD
Hydroxyurea—Diarrhoea—Doxorubicin—muscle cancer	4.98e-05	0.000402	CcSEcCtD
Hydroxyurea—Dizziness—Doxorubicin—muscle cancer	4.81e-05	0.000389	CcSEcCtD
Hydroxyurea—Vomiting—Doxorubicin—muscle cancer	4.63e-05	0.000374	CcSEcCtD
Hydroxyurea—Rash—Doxorubicin—muscle cancer	4.59e-05	0.000371	CcSEcCtD
Hydroxyurea—Dermatitis—Doxorubicin—muscle cancer	4.59e-05	0.00037	CcSEcCtD
Hydroxyurea—Headache—Doxorubicin—muscle cancer	4.56e-05	0.000368	CcSEcCtD
Hydroxyurea—Nausea—Doxorubicin—muscle cancer	4.33e-05	0.000349	CcSEcCtD
Hydroxyurea—CYP2D6—Melatonin metabolism and effects—FOXO1—muscle cancer	3.9e-05	0.0164	CbGpPWpGaD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—CDKN2A—muscle cancer	3.7e-05	0.0156	CbGpPWpGaD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—TP53—muscle cancer	3.55e-05	0.015	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	3.3e-05	0.0139	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—FH—muscle cancer	3.3e-05	0.0139	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	3.18e-05	0.0134	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—BUB1B—muscle cancer	2.97e-05	0.0125	CbGpPWpGaD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—TP53—muscle cancer	2.92e-05	0.0123	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—FH—muscle cancer	2.71e-05	0.0114	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—BUB1B—muscle cancer	2.65e-05	0.0112	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	2.51e-05	0.0106	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	1.89e-05	0.00798	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—MED12—muscle cancer	1.86e-05	0.00785	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—ENO2—muscle cancer	1.7e-05	0.00716	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—MED12—muscle cancer	1.53e-05	0.00646	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—ENO2—muscle cancer	1.4e-05	0.00589	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—CDKN2A—muscle cancer	1.36e-05	0.00571	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—CDKN2A—muscle cancer	1.21e-05	0.00511	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—MDM2—muscle cancer	1.18e-05	0.00496	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—TP53—muscle cancer	6.75e-06	0.00284	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—PTGS2—muscle cancer	5.91e-06	0.00249	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—FH—muscle cancer	5.17e-06	0.00218	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PTGS2—muscle cancer	4.87e-06	0.00205	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—MED12—muscle cancer	2.92e-06	0.00123	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ENO2—muscle cancer	2.66e-06	0.00112	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PTGS2—muscle cancer	9.28e-07	0.000391	CbGpPWpGaD
